# NORTHEAST BIOLAB – FDA Inspection, Jul 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/northeast-biolab/775ac5bb-fc0a-4837-be6b-e1e405f36024
Source feed: FDA_Inspections

> FDA inspection 1326756 of NORTHEAST BIOLAB, July 17, 2026. 6 citations under 21 CFR part 58. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1326756
- Company Name: NORTHEAST BIOLAB
- Inspection Date: 2026-07-17
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1302606 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/northeast-biolab/a8c74c4f-6355-45ee-8d7e-4c113b6299c0)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/agata-e-libera/ab9679b1-cd55-452e-bdf3-dd22f67f4e0c)
- [Company Rep](https://www.keypedia.com/people/barbara-d-wright/c824bcb9-76fb-4e83-86d0-013a9584c137)
- [Issuing Officer](https://www.keypedia.com/people/darbra-r-blankenship/d0186717-dbc8-4981-a489-103b781ca92b)

Company: https://www.keypedia.com/companies/northeast-biolab/df8bbc09-ec35-4998-88e5-8b66c2764e36

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
